OHE Publications

OHE releases a number of publications throughout the year, authored by OHE team members and/or outside experts. All are free for download as pdf files; hard copies of some publications are available upon request.

A description of the OHE publications categories.


 

Towse, A. and Henshall, C.

Briefing
April 2017

The HTAi Asia Policy Forum meeting 2013 was held in Seoul, 13th -14th June 2013. This was the first of several annual meetings of the HTAi Asia Policy Forum. The topic of the meeting was: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

This report represents the background paper for the meeting, as developed by OHE. The report begins by looking at the increasing interest in the use of HTA, how HTA has evolved, where HTA has got to in Asia.

Barnsley, P., Hampson, G., Towse, A. and Henshall, C.

Briefing
April 2017

The second HTAi Asia Policy Forum meeting (2014) was held in Manilla, 10th -11th June 2014. The topic of the meeting was: Transferability of HTA. This report represents the background paper for the meeting, as developed by OHE.

Hampson, G., Towse, A. and Henshall, C.

Briefing
April 2017

The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th November 2016. The topic of the meeting was: Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies. This report represents the background paper for the meeting, as developed by OHE.

The paper begins with a discussion of how value can be defined, measured and factored into decisions on access and coverage.

Cubi-Molla, P., Shah, K.K., Garside, J., Herdman, M. and Devlin, N.

Research Paper
April 2017

Several studies have found differences in health state values by age. We investigate whether and how age affects respondents’ Time Trade-Off (TTO) and Visual Analogue Scale (VAS) valuations of hypothetical EQ-5D health states using data from the 1993 MVH UK valuation study. 

Marsden, G., Towse, A., Pearson, S.D., Dreitlein, B. and Henshall, C.

Research Paper
March 2017

This report presents an analysis of the significant clinical potential of gene therapy and the unique challenges in developing and evaluating evidence on their effectiveness and value. Special attention is given to pricing and payment mechanisms, including new approaches to payment based on long-term amortization of initial costs.

Hicks, N.

Seminar Briefing
February 2017

This OHE Seminar Briefing summarises a seminar given by Dr Nicholas Hicks, Co-founder and Chief Executive of COBIC (Capitated Outcomes-Based Incentivised Care). Dr Hicks describes COBIC’s outcomes-centred approach that has been adopted by NHS services across England and that brings together commissioners, providers, other professions, patients and carers.

Marsden, G. and Towse, A.

Consulting Report
February 2017

In 2016 the University of York undertook a review exercise to determine whether NICE’s existing methods and processes are appropriate for assessment of regenerative medicines. The purpose of this OHE report is to explore this review exercise and to assess whether or not the resulting conclusions are appropriate.

Hernandez-Villafuerte, K., Garau, M., Towse, A., Garrison, L. and Grewal, S.

Consulting Report
January 2017

PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion.

This report presents a framework for developing medicines formularies which combines macro-level decision making factors (focusing on the health system organisation and its priority setting), and micro-level factors (looking at intervention-specific effects) to determine the overall value of medicines.

O'Neill, P., Cole, A., Duran, A. and Devlin, N.

Research Paper
December 2016

This Research Paper explores decisions by the National Institute for Health and Care Excellence (NICE) that new technologies are to be recommended in line with clinical practice (RiLCP). The authors qualitatively assess documentation associated with RiLCP decisions to create a framework to describe common themes, and assess the level of patient access associated with each RiLCP decision.

Barnsley, P., Cubi-Molla, P., Fischer, A., and Towse, A.

Research Paper
November 2016

The quality of decision-making in key public sector bodies dealing with resource allocation is a major determinant of their efficiency. One of the most difficult and contentious areas of decision-making is the way that uncertainty is dealt with.

Pages